valbenazine: Clinical Trials

6 trials of valbenazine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 withdrawn. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 4, Recruiting 1, Withdrawn 1

Follow valbenazine: new trials by email Literature Review of valbenazine trials Research Report on valbenazine

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Valbenazine - Schizophrenia, Schizoaffective Disorder
Phase 4RecruitingNeurocrine Biosciences1002025-08-292026-09-18
Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities
Valbenazine Oral Capsule - Tardive Dyskinesia, Intellectual Disability
Phase 4WithdrawnStephen Ruedrich2025-01-012024-10-24
Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia
Valbenazine - Schizophrenia, Schizoaffective Disorder
Phase 4CompletedNeurocrine Biosciences592023-05-092026-01-16
Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia
Ingrezza Pill - Cervical Dystonia
Phase 4CompletedThe Orthopedic Foundation202021-10-192023-10-06
Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia
Valbenazine, Placebo oral capsule - Tardive Dyskinesia (TD)
Phase 4CompletedNeurocrine Biosciences1352019-03-182021-04-20
The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine
Valbenazine, Placebo oral capsule - Tardive Dyskinesia (TD)
Phase 4CompletedNeurocrine Biosciences892018-09-142020-06-04

Conditions studied

Tardive Dyskinesia (5)  ·  Bipolar Disorder (2)  ·  Depressive Disorder, Major (2)  ·  Psychotic Disorders (2)  ·  Schizophrenia (2)  ·  Caregiver Burden (1)  ·  Developmental Disabilities (1)  ·  Intellectual Disability (1)  ·  Movement Disorders (1)  ·  Torticollis (1)

Sponsors

Neurocrine Biosciences (4)  ·  Stephen Ruedrich (1)  ·  The Orthopedic Foundation (1)

Countries

United States (6)  ·  Puerto Rico (2)

Top investigators

Martin Taylor, DO, PHD (1)  ·  Stephen Ruedrich, MD (1)